"Calcineurin Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit or block the PHOSPHATASE activity of CALCINEURIN.
| Descriptor ID |
D065095
|
| MeSH Number(s) |
D27.505.519.389.174
|
| Concept/Terms |
Calcineurin Inhibitors- Calcineurin Inhibitors
- Protein Phosphatase-2B Inhibitors
- Protein Phosphatase 2B Inhibitors
- Protein Phosphatase 3 Inhibitors
- Calcineurin Antagonists
- Calcineurin Blockers
|
Below are MeSH descriptors whose meaning is more general than "Calcineurin Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Calcineurin Inhibitors".
This graph shows the total number of publications written about "Calcineurin Inhibitors" by people in this website by year, and whether "Calcineurin Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2012 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 11 | 10 | 21 |
| 2018 | 10 | 10 | 20 |
| 2019 | 6 | 3 | 9 |
| 2020 | 2 | 3 | 5 |
| 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Calcineurin Inhibitors" by people in Profiles.
-
Reply to: "Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients". J Hepatol. 2021 07; 75(1):228-229.
-
Reply letter to: Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: Are concentrations required clinically achievable? J Intern Med. 2021 06; 289(6):928-929.
-
Voclosporin: First Approval. Drugs. 2021 Apr; 81(5):605-610.
-
Effect of Calcineurin Inhibitors and Mammalian Target of Rapamycin Inhibitors on the Course of COVID-19 in Kidney Transplant Recipients. Ann Transplant. 2021 Mar 12; 26:e929279.
-
SARS-CoV-2 Serologic Immune Response in Exogenously Immunosuppressed Patients. J Appl Lab Med. 2021 03 01; 6(2):486-490.
-
Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: are concentrations required clinically achievable? J Intern Med. 2021 06; 289(6):926-927.
-
Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus via interferon-? in vitro and in mice. Eur Respir J. 2020 Nov; 56(5).
-
COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: A systematic review of cases. Transpl Infect Dis. 2020 Dec; 22(6):e13427.
-
Guidance on the special care of liver or kidney transplant recipients diagnosed with COVID-19 Orv Hetil. 2020 08; 161(32):1310-1321.
-
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. J Hepatol. 2021 01; 74(1):148-155.